What Is Putting Cigna Group (CI) Back In Focus?
Cigna Group (CI) has drawn fresh attention after recent share price moves put its current valuation back in focus for health insurance and pharmacy benefits investors who are watching large, diversified healthcare platforms.
The recent move in Cigna Group’s share price to US$288.90 comes after a mixed stretch, with a 7 day share price return of 4.7% but a small decline over the last session. This hints at investors rebalancing short term enthusiasm against a more measured view of long term total shareholder return, including the 5 year total shareholder return of 56.7%.
Benchmark Cigna Group against a curated set of insurers and healthcare platforms by scanning the 11 resilient stocks with low risk scores that have shown resilience in recent market swings.
The latest move in Cigna Group’s share price could reflect investors reassessing the underlying Evernorth and Cigna Healthcare operations, or it could be mostly sentiment resetting after a strong multi year run. How does the current valuation line up with those possibilities?
Most Popular Narrative: 55% Undervalued
Cigna Group’s most followed narrative pegs fair value at about $636 per share against the latest close of $288.90. This frames the current share price as a steep discount that still needs to be underwritten against real business risks.
Cigna trades 55% below what our model says it is worth. An insurer would never quote a policy from a number that seductive without reading the exclusions, inspecting the claims history, and asking what could go catastrophically wrong. So neither did we, and the file contains a fair, intelligent case for disagreeing with our verdict.
See why 2 investors see Cigna Group as 55% undervalued.
Result: Fair Value of $636.28 (UNDERVALUED)
Still, the ongoing PxDx litigation and decade long FTC monitoring of Express Scripts could both weaken confidence in Cigna Group’s valuation story if the outcomes turn adverse.
Find out about the key risks to this Cigna Group narrative.
Next Steps
If the mix of risks and rewards around Cigna Group feels finely balanced, act quickly and test the numbers yourself using the 5 key rewards and 1 important warning sign.
Looking for more investment ideas beyond Cigna Group?
If Cigna Group has sharpened your focus on quality, do not stop here. Broader research across sectors can reveal opportunities that better match your own risk and return preferences.
- Target resilient balance sheets that can absorb shocks while still supporting growth by scanning the list of solid balance sheet and fundamentals (22 results).
- Hunt for potential value opportunities where quality and pricing line up sensibly by reviewing the 34 high quality undervalued stocks.
- Prioritise steady cash returns if income is a key part of your plan by assessing the 6 dividend fortresses.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com